EUVIMEDEUVIMED entdecken
Crossref

Tumoral Pharmacokinetic–Pharmacodynamic Simulation of Doxorubicin-Encapsulated Polymeric Micelles Using a Tissue-Isolated Tumor Perfusion System

Shugo Yamashita iD, Shunsuke Kimura, Akiko Kiriyama iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00729 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Shugo Yamashita und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kyotanabe, Kyoto 610-0395, Japan. Hauptthemen laut MEDLINE: Doxorubicin, Micelles, Polymers, Microdialysis. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacokinetic (PK) elucidation of polymeric micelles delivering anticancer drugs is crucial for accurate antitumor PK-pharmacodynamic (PK-PD) simulations. Particularly, establishing a methodology to quantify the tumor inflow and outflow of anticancer drugs encapsulated in polymeric micelles is an essential challenge. General tumor biodistribution experiments are disadvantageous in that inflow quantification is easy, but outflow quantification is challenging. We addressed this issue by proposing a quantification method that combines a tissue-isolated tumor perfusion system with microdialysis. This method aims to determine tumoral drug inflow and outflow by quantifying the drugs released from the polymeric micelles via a tumor-embedded microdialysis probe and perfusate, respectively. Furthermore, we evaluated the feasibility of this method by perfusing pH-sensitive polyethylene glycol-poly(aspartate-hydrazone-doxorubicin/phenylalanine)n (PPDF-Hyd-DOX) in a tissue-isolated tumor perfusion system, and we quantified tumor inflow and outflow released DOX. Based on the quantitative results, we performed compartmental analyses by incorporating the gamma-distributed delay function and calculated the PK rate constants. These parameters were input into a tumor-bearing rat compartment model for ex vivo-in vivo extrapolation (EVIVE) of the rat plasma PPDF-Hyd-DOX concentrations and simulated intratumorally released DOX concentrations. The simulation profiles demonstrated a good fit with the Walker 256 intratumoral released DOX concentration profiles previously reported. This EVIVE-PK model was coupled with the threshold natural-growth tumor PD model, and PK-PD analysis was performed. This model exhibited a better fit to the tumor weight profile of Walker 256-bearing rats treated with PPDF-Hyd-DOX than that of our previously reported PK-PD model. Thus, EVIVE, based on a tissue-isolated tumor perfusion system with microdialysis, is a promising approach for the PK-PD simulation of polymeric micelle anticancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinMicellesPolymersMicrodialysisAnimalsRatsTissue DistributionPolyethylene GlycolsPerfusionMaleCell Line, TumorAntibiotics, AntineoplasticNeoplasmsDrug Delivery Systems

Stichwörter der Autor:innen

controlled releaseex vivo−in vivo extrapolationpharmacokinetic-pharmacodynamicpolymeric micelletissue-isolated tumor perfusion

Substanzen

DoxorubicinMicellesPolymersPolyethylene GlycolsAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Department of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kyotanabe, Kyoto 610-0395, Japan.

ORCID-Profile: Shugo Yamashita, Akiko Kiriyama

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Yamashita, S., Kimura, S., & Kiriyama, A. (2024). Tumoral Pharmacokinetic–Pharmacodynamic Simulation of Doxorubicin-Encapsulated Polymeric Micelles Using a Tissue-Isolated Tumor Perfusion System. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00729

Vancouver

Yamashita S, Kimura S, Kiriyama A. Tumoral Pharmacokinetic–Pharmacodynamic Simulation of Doxorubicin-Encapsulated Polymeric Micelles Using a Tissue-Isolated Tumor Perfusion System. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00729

BibTeX
@article{Yamashita2024,
  author = {Yamashita, Shugo and Kimura, Shunsuke and Kiriyama, Akiko},
  title = {Tumoral Pharmacokinetic–Pharmacodynamic Simulation of Doxorubicin-Encapsulated Polymeric Micelles Using a Tissue-Isolated Tumor Perfusion System},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00729}
}
Kostenlos starten →